GSA Capital Partners LLP Purchases New Stake in Inspire Medical Systems, Inc. $INSP

Posted by Francis Steltz on Aug 19th, 2026

GSA Capital Partners LLP acquired a new stake in Inspire Medical Systems, Inc. (NYSE:INSP – Free Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 18,382 shares of the company’s stock, valued at approximately $820,000. GSA Capital Partners LLP owned about 0.06% of Inspire Medical Systems at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. CWM LLC boosted its holdings in shares of Inspire Medical Systems by 216.1% during the 4th quarter. CWM LLC now owns 354 shares of the company’s stock worth $33,000 after buying an additional 242 shares during the period. EverSource Wealth Advisors LLC grew its stake in Inspire Medical Systems by 1,115.4% in the 1st quarter. EverSource Wealth Advisors LLC now owns 632 shares of the company’s stock valued at $33,000 after buying an additional 580 shares during the last quarter. Havemeyer Place LP bought a new position in Inspire Medical Systems in the 4th quarter valued at about $39,000. Smartleaf Asset Management LLC raised its holdings in Inspire Medical Systems by 84.0% in the 4th quarter. Smartleaf Asset Management LLC now owns 449 shares of the company’s stock valued at $42,000 after acquiring an additional 205 shares during the period. Finally, Versant Capital Management Inc raised its holdings in Inspire Medical Systems by 379.0% in the 2nd quarter. Versant Capital Management Inc now owns 958 shares of the company’s stock valued at $43,000 after acquiring an additional 758 shares during the period. 94.91% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the company. Royal Bank Of Canada restated a “sector perform” rating and set a $60.00 price objective on shares of Inspire Medical Systems in a report on Tuesday, August 4th. Piper Sandler increased their target price on Inspire Medical Systems from $55.00 to $60.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 4th. Truist Financial reissued a “hold” rating and set a $62.00 price target (up from $54.00) on shares of Inspire Medical Systems in a report on Tuesday, August 4th. Mizuho lifted their price target on Inspire Medical Systems from $55.00 to $65.00 and gave the stock an “outperform” rating in a report on Tuesday, August 4th. Finally, Evercore set a $54.00 price target on Inspire Medical Systems in a research note on Tuesday, August 4th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, twelve have issued a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, Inspire Medical Systems presently has an average rating of “Hold” and a consensus price target of $66.19.

Read Our Latest Research Report on Inspire Medical Systems

Insider Buying and Selling

In other Inspire Medical Systems news, insider Jason P. Kelly sold 963 shares of Inspire Medical Systems stock in a transaction on Friday, August 7th. The stock was sold at an average price of $59.55, for a total value of $57,346.65. Following the completion of the transaction, the insider directly owned 18,985 shares of the company’s stock, valued at $1,130,556.75. The trade was a 4.83% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.20% of the stock is currently owned by company insiders.

Inspire Medical Systems Stock Up 0.4%

Shares of Inspire Medical Systems stock opened at $57.43 on Wednesday. The stock has a market capitalization of $1.66 billion, a price-to-earnings ratio of 12.43, a price-to-earnings-growth ratio of 4.34 and a beta of 0.70. Inspire Medical Systems, Inc. has a twelve month low of $38.91 and a twelve month high of $147.03. The company has a 50-day simple moving average of $49.98 and a two-hundred day simple moving average of $52.92.

Inspire Medical Systems (NYSE:INSP – Get Free Report) last announced its earnings results on Monday, August 3rd. The company reported $0.14 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.24) by $0.38. Inspire Medical Systems had a net margin of 15.03% and a return on equity of 8.64%. The firm had revenue of $200.58 million for the quarter, compared to analyst estimates of $194.72 million. During the same quarter in the prior year, the business posted $0.45 EPS. The business’s revenue was down 7.6% compared to the same quarter last year. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. On average, sell-side analysts anticipate that Inspire Medical Systems, Inc. will post 1.24 earnings per share for the current fiscal year.

About Inspire Medical Systems

(Free Report)

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.